Symrise AG (SY1) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Symrise AG stock €30.89, price €97.96, that is 68.5% below the price, quality 62 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range €65.72 – €123.90 · fair‑value band €23.17 – €40.57 · the €97.96 price screens above the €30.89 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Symrise in your weekly email
Every Wednesday you see whether Symrise is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Symrise AG operates as a supplier of fragrances, flavorings, cosmetic base materials and active ingredients, and functional ingredients and solutions in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America.
Show moreShow less
It operates in two segments, Taste, Nutrition & Health; and Scent & Care.
The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; sweets, chocolate, chewing gum, baked goods, cereals, ice cream, milk, yogurt and milk alternatives; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances.
This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. The company was founded in 1874 and is headquartered in Holzminden, Germany.
Stock analysis
Symrise AG (SY1) currently trades at €97.96, while our model-based Fair Value estimate is €30.89, 68% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of €58.43 per share, and 0 of the 26 models we run sit above the €97.96 price.
Bear case: the Asset-Based group reads lowest at €6.04, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: €23.17 (bear) to €40.57 (bull), the price of €97.96 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Symrise AG reported revenue of €4.9B in FY2025 versus €3.8B in FY2021, a compound +6.5%/yr. Reported net income was €249M in FY2025, compounding −9.7%/yr from FY2021.
Key figures
Market cap €13.6B Large · P/E ratio 55.3 · P/S ratio 2.76 · EPS (TTM) €1.77 · Dividend yield 1.3% · Net margin 5.0% · Return on equity 6.7% · Return on assets (EBIT) 7.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 44 out of 100 (low confidence).
What moves the price
The share trades about 4% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −44% fair-value upside, at −68%, SY1 screens richer than that median.
Fair Value models
Bear€23.17Fair Value €30.89Bull€40.57
Price €97.96 · Downside -68.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.4416 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.68/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−1.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
Start year 2020 (pandemic). Over 10 years: +6.6% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−2.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.1%
Dividend (yield on the price)1.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−4.1% vs −0.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 12%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+11.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.7%
Yearly sales growth analysts expect, extended to five years.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +9.0% a year for the price and +1.5% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (81 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
AI conclusion: Symrise's main strength is the integrated natural fragrance cluster in Grasse under the ONE Symrise strategy, while its main weak point is the thin evidence of a durable moat and margins that are not exceptional versus peers.
Main risk: The naturals push risks mainly adding operational complexity that fails to lift overall growth and hits the company's expansion trajectory.
Bull case: Symrise could strengthen its compliance systems and use its backward-integrated natural sourcing and AI tools like Philyra to differentiate offerings and maintain customer loyalty despite regulatory scrutiny.
Bear case: If the investigations result in significant fines or restrictions, Symrise might face higher compliance costs, reduced pricing flexibility and slower innovation in its Scent & Care segment, limiting growth in key markets.
Symrise has expanded its natural fragrance capabilities by completing the Floral Concept acquisition and opening a new Lautier 1795 site, forming a dedicated cluster in Grasse. This move integrates sourcing, production and creation under the ONE Symrise strategy. Our models currently see the stock as overvalued. Will the naturals push drive lasting competitive edges or mainly add complexity without lifting overall growth?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 727 stocks
Beats the industry median on 3/15 measures
Overall it trails its industry peers.
Valuation
Quality Score62 · Top 25%
Fair Value upside−68.5% · Bottom 25%
Profitability
Return on equity (12 months)6.7% · Above median
Return on assets3.1% · Below median
Net margin (12 months)5.0% · Below median
Operating margin (12 months)15.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)−0.6% · Bottom 25%
Dividend yield (12 months)1.3% · Below median
Balance sheet
Debt / equity0.55× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)55.3× · Priciest 25%
P/B3.65× · Priciest 25%
P/S (12 months)2.76× · Pricier than median
Price / free cash flow26.0× · Pricier than median
EV/EBITDA20.2× · Priciest 25%
PEG2.99× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 67
PAST (return on equity)27· sector 27
HEALTH (low debt)72· sector 95
DIVIDEND (yield)26· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Symrise AG Fair Value". https://www.fairvalue-calculator.com/stock/SY1
Frequently asked questions
Is Symrise AG (SY1) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of €30.89 versus a price of €97.96, about 68% lower (overvalued).
What is the fair value of SY1?
Our model-based fair value for Symrise AG is €30.89 (as of Nov 6, 2026), built from audited fundamentals. The current price: €97.96.
What is the quality score of SY1?
Symrise AG has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Symrise AG (SY1)?
Our model-based price target is the fair value of €30.89 (as of Nov 6, 2026) from 26 valuation models. Cautious scenario €23.17, optimistic scenario €40.57. It is a calculation from audited fundamentals, not an analyst target.
What is the Symrise AG stock forecast for 2026?
Our models put fair value at €30.89, about 68% lower versus a price of €97.96 (overvalued). Cautious scenario €23.17, optimistic scenario €40.57. The calculation is refreshed regularly with new filings.
What is the revenue of Symrise AG (SY1)?
Symrise AG reported trailing-twelve-month revenue of about €4.9B (latest available figure, as of Nov 6, 2026).
Does Symrise AG pay a dividend?
Symrise AG currently shows a dividend yield of 1.28% relative to its recent price (as of Nov 6, 2026).
What growth is priced into Symrise AG (SY1)?
For today's price to be fair in a discounted-cash-flow model, Symrise AG would have to grow free cash flow by +11.4 % per year for five years (discount rate 8.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.0 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of SY1 use?
Our models discount Symrise AG at 8.0 %: a base by market capitalisation (large), damped by beta 0.57, country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Symrise AG that is +11.4 % per year a year over ten years, using the same discount rate (8.0 %) and the same formula as our fair value.
How much growth has Symrise AG (SY1) delivered so far?
Over the past 5 years revenue at Symrise AG grew +7.0 % a year. The price currently implies +11.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Symrise AG (SY1) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Symrise AG (+11.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Symrise AG (SY1)?
The free-cash-flow yield on the price is 3.84 %: that much free cash flow Symrise AG produces per unit of market value. When it exceeds the discount rate of our models (8.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Symrise AG (SY1)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Symrise AG it is €30.89 per share (as of Nov 6, 2026), against a price of €97.96. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Symrise AG stock overvalued or undervalued in 2026?
As of Nov 6, 2026, SY1 trades above its calculated fair value: price €97.96, fair value €30.89, a gap of about −68% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SY1?
No. The price is what the market pays today (€97.96); the fair value is what the company's own numbers justify (€30.89). For Symrise AG the two are €67.07 per share apart. That gap is exactly why we show both numbers side by side.
How much is Symrise AG worth?
The market values Symrise AG at about €13.6B (market capitalisation, as of Nov 6, 2026). Per share that is €97.96; our models calculate a fair value of €30.89 per share.
What do the bullish and bearish scenarios say about SY1?
Our models span a range for Symrise AG: cautious scenario €23.17, base €30.89, optimistic €40.57 per share (as of Nov 6, 2026, price €97.96). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SY1?
Symrise AG trades at a price-to-earnings ratio of 55.3 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €30.89 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 39.8. Other multiples: PEG 3.0, P/B 3.7, P/S 2.8, EV/EBITDA 20.2.
What is the PEG ratio of SY1?
The PEG ratio of Symrise AG is 2.99 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Symrise AG (SY1)?
Balance-sheet figures for Symrise AG (as of Nov 6, 2026): return on equity 6.7%, debt of 0.55 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is SY1 from its 52-week high?
Symrise AG trades at €97.96, about 4% below its 52-week high of €102.30 and 49% above the low of €65.72 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of €30.89 is for.
Which stocks are comparable to Symrise AG?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Symrise AG stock attractive at the current price?
The data as of Nov 6, 2026: price €97.96, calculated fair value €30.89 (−68%), Quality Score 62/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SY1 calculated?
We run Symrise AG through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €30.89, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Symrise AG itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Symrise AG (SY1)?
The closing price on Nov 5, 2026 was €97.96. Our model-based fair value is €30.89, about 68% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Symrise AG right now?
The price sits above even our optimistic bull case (€40.57). The favourable scenario is already priced in. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Symrise AG (SY1) come from?
Earnings per share at Symrise AG grew +4.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +6.5 %, EBIT margin −1.3 %, tax rate −0.1 %, residual (interest, one-offs) −0.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Symrise AG
How large is the market capitalisation of Symrise AG (SY1)?
The market capitalisation of Symrise AG is €13.6B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Symrise AG (SY1)?
The price-to-sales ratio of Symrise AG is 2.76 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Symrise AG (SY1)?
Earnings per share at Symrise AG are €1.77 (price ÷ EPS = P/E 55.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Symrise AG (SY1)?
The dividend yield of Symrise AG is 1.3% (payout 70.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Symrise AG (SY1)?
The net margin of Symrise AG is 5.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Symrise AG (SY1)?
The return on equity (ROE) of Symrise AG is 6.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Symrise AG (SY1)?
On an EBIT basis the return on assets of Symrise AG is 7.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Symrise AG (SY1)?
The operating margin of Symrise AG is 15.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Symrise AG (SY1)?
Revenue at Symrise AG is growing −0.6% versus a year earlier (3y avg +2.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Symrise AG (SY1)?
Earnings per share at Symrise AG are growing −0.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Symrise AG (SY1) carry?
The net debt of Symrise AG is €1.6B (fiscal year 2025, ≈ 3.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Symrise AG in the live analysis
One click puts Symrise AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 6, 2026